21:39 , Nov 30, 2018 |  BC Week In Review  |  Company News

Boston Scientific to acquire London-based BTG

Boston Scientific Corp. (NYSE:BSX) will acquire BTG plc (LSE:BTG) for about £3.3 billion ($4.2 million) in cash. BTG shareholders will receive 840p per share. The acquisition is expected to close 1H19. BTG develops products used...
17:26 , Sep 14, 2018 |  BC Week In Review  |  Company News

Boston Scientific to acquire Augmenix for $500M

Boston Scientific Corp. (NYSE:BSX) will acquire Augmenix Inc. (Waltham, Mass.) for $500 million in cash up front and up to $100 million in sales milestones. Boston Scientific will gain Augmenix's SpaceOAR hydrogel, which is used...
21:15 , Oct 9, 2017 |  BC Extra  |  Politics & Policy

Patient engagement panel to focus on trial participation

Improving clinical trial recruitment, retention and results communication will be the focus of the inaugural meeting of FDA's Patient Engagement Advisory Committee (PEAC) on Oct. 11-12. In background materials posted by FDA's Center for Devices...
18:33 , Sep 8, 2017 |  BioCentury  |  Finance

Rig-ging an exit

Wellington Partners’ quick exit from Rigontec GmbH will not only be one of the firm’s best returns from its current fund, but could bolster its fund-raising efforts for a third life sciences fund. On Sept....
23:01 , May 15, 2017 |  BC Extra  |  Company News

Duke-Margolis forms value-based payment consortium

The Duke-Margolis Center for Health Policy said a newly formed consortium intends to explore issues tied to value-based payments for drugs, devices and gene technologies. The center said the consortium aims to overcome legal and...
07:00 , May 11, 2015 |  BC Week In Review  |  Financial News

Boston Scientific completes private placement of senior notes

Boston Scientific Corp. (NYSE:BSX), Natick, Mass.   Business: Cardiovascular   Date completed: 2015-05-07   Type: Private placement of senior notes   Raised: $1.9 billion   Investor: Existing investors   Underwriters: Barclays Capital; Citigroup; Deutsche Bank;...
07:00 , Mar 23, 2015 |  BC Week In Review  |  Company News

Endo International pl, Boston Scientific deal

Boston Scientific will purchase Endo’s American Medical Systems (AMS) urology medical device portfolio for $1.6 billion in cash up front, plus a $50 million milestone based on 2016 sales. In 2014, the AMS unit had...
07:00 , Mar 16, 2015 |  BioCentury  |  Tools & Techniques

Harnessing data for AD

A new initiative from the Global CEO Initiative on Alzheimer's Disease and Optum Labs aims to harness big data sets and analysis tools to better identify patients at risk for developing Alzheimer's disease. The partners...
07:00 , Sep 8, 2014 |  BC Week In Review  |  Company News

Bayer, Boston Scientific deal

Medical device company Boston Scientific completed its purchase of Bayer's interventional device business for $415 million in cash up front. The amount includes undisclosed fees for transitional services (see BioCentury, May 26). Bayer AG (Xetra:BAYN),...
07:00 , May 26, 2014 |  BC Week In Review  |  Company News

Boston Scientific, Bayer deal

Medical device company Boston Scientific will purchase Bayer's interventional device business for $415 million in cash up front. The amount includes undisclosed fees for transitional services. The business includes the AngioJet Ultra Thrombectomy System to...